Chikungunya Outbreak in Mauritius: What US Travelers Need to Know Before You Go

Mauritius is in the middle of a fast-moving chikungunya outbreak. The Mauritius Ministry of Health & Wellness has reported 2,816 confirmed locally acquired cases between January and 11 May 2026, concentrated in the lower and middle Plaines Wilhems districts on the main island. On 14 May 2026, the CDC reviewed and reaffirmed a Level 2 Travel Health Notice for Mauritius, advising US travelers to practice enhanced precautions, vaccinate with Ixchiq if eligible, and reconsider non-essential travel late in pregnancy. Chikungunya is rarely fatal, but joint pain after infection can last weeks to months and is severe enough to disrupt the rest of an itinerary. The Ixchiq chikungunya vaccine is FDA-approved for adults 18 and older and is the single most effective intervention available before travel. Our clinicians at Wandr have been routing Mauritius-bound travelers to Ixchiq plus an aggressive mosquito-bite prevention plan, and travelers who are pregnant, immunocompromised, or older than 65 should book a pre-trip review with us before departure.

Quick facts: Mauritius chikungunya outbreak as of 21 May 2026

• CDC level: Level 2, Practice Enhanced Precautions (reviewed 2026-05-14)
• Cases reported: 2,816 confirmed locally acquired cases between January and 11 May 2026, per the Mauritius Ministry of Health & Wellness
• Geographic concentration: Lower and middle Plaines Wilhems district (central Mauritius, includes Curepipe, Vacoas-Phoenix, Quatre Bornes, Beau Bassin-Rose Hill)
• Disease: Chikungunya virus, transmitted by Aedes aegypti and Aedes albopictus mosquitoes
• Case fatality: Less than 0.1 percent, but long-term joint pain (chronic chikungunya arthritis) in roughly 30 to 40 percent of cases
• Vaccine available: Yes. Ixchiq (live-attenuated chikungunya vaccine), FDA-approved for adults 18 and older in November 2023; available through Wandr partner pharmacies
• Travelers most at risk: Pregnant women near delivery, infants, adults over 65, anyone immunocompromised, and anyone with chronic joint disease

What is chikungunya, and how is it different from dengue?

Chikungunya is a mosquito-borne viral illness that produces sudden high fever and severe joint pain. The name comes from a Kimakonde word meaning "to become contorted," describing the stooped posture of people with severe joint pain. It is rarely fatal, with less than 1 in 1,000 cases ending in death, but it is genuinely miserable. The acute illness lasts 7 to 10 days. About 30 to 40 percent of people develop lingering joint pain that can last weeks to months, sometimes longer than a year per the World Health Organization.

Many US travelers conflate chikungunya with dengue because both are transmitted by the same Aedes mosquitoes and can co-circulate in the same destinations. The clinical distinction matters:

Both viruses circulate in Mauritius. The 2026 outbreak is chikungunya, but we still recommend dengue precautions for the same itinerary.

Why the 2026 Mauritius outbreak is significant

Mauritius has experienced chikungunya before. The country reported a large outbreak in 2005 to 2006 that infected an estimated 38 percent of the population, before vaccines existed. The current 2026 outbreak is the first major regional event since chikungunya vaccines became available in the US, and it follows similar outbreaks in nearby Indian Ocean islands. The European Centre for Disease Prevention and Control reported sustained transmission across La Réunion, Mayotte, the Seychelles, and Comoros in 2025, with Mauritius cases climbing through the first quarter of 2026.

The CDC Level 2 designation means three things for US travelers:

1. Travel is not banned, but enhanced precautions are required. Bug-bite prevention is no longer optional, it is the trip plan.
2. Vaccination is recommended for most travelers. The CDC specifically advises Ixchiq for adults 18 and older traveling to an area with an active outbreak, unless contraindicated.
3. Pregnant women near delivery should reconsider travel. Maternal-to-newborn transmission of chikungunya around the time of delivery carries a significantly higher risk of severe neonatal disease.

This is the rare CDC notice where the right answer is not "be careful" but "do something specific before you go." That specific something is the chikungunya vaccine.

The Ixchiq chikungunya vaccine: what to know

Ixchiq is the first FDA-approved chikungunya vaccine in the United States, licensed in November 2023. It is a single-dose, live-attenuated vaccine administered intramuscularly, indicated for adults 18 and older at increased risk of exposure to chikungunya virus.

Key facts from the FDA prescribing information and CDC ACIP recommendations:

• Dose: Single 0.5 mL intramuscular injection
• Onset of protection: Approximately 28 days after vaccination
• Duration: Antibody titers above the seroresponse threshold remain elevated through at least 24 months in clinical trials; ongoing studies expected to support longer-term durability
• Efficacy: In Phase 3 trials, 98.9 percent of recipients achieved seroresponse 28 days after a single dose
• Side effects: Most commonly headache, fatigue, muscle pain, joint pain, fever, nausea, and tenderness at the injection site. About 1.6 percent of trial participants reported severe chikungunya-like reactions
• Not recommended for: Adults 65 and older with comorbidities have been associated with serious adverse events in post-marketing reports; the ACIP currently recommends shared clinical decision-making for this group. Pregnancy and immunocompromise are contraindications

Mosquito-bite prevention: the non-negotiable layer

The vaccine reduces your risk, but it does not eliminate it, and it takes 28 days to take effect. Mosquito-bite prevention is the second half of the protection plan, and for travelers who cannot take Ixchiq (pregnant, immunocompromised, under 18, allergic) it is the entire plan.

The Aedes mosquitoes that transmit chikungunya bite during the day, with peak biting activity in the early morning and late afternoon, unlike malaria-carrying Anopheles mosquitoes which bite at night. The implication: covering up at dusk is not enough.

Evidence-based prevention layers:

1. Repellent on exposed skin. Use an EPA-registered product with 20 to 30 percent DEET, 20 percent picaridin, IR3535, or oil of lemon eucalyptus (OLE; do not use on children under 3). Apply every 4 to 6 hours during peak biting times. The CDC and WHO consensus is that DEET and picaridin are the most effective for Aedes mosquitoes.
2. Permethrin-treated clothing. Permethrin spray applied to shirts, pants, socks, and hats provides residual protection through 5 to 6 washes. Pre-treated clothing is also commercially available. Do not apply permethrin to skin.
3. Cover up where possible. Long-sleeve shirts and long pants in lightweight breathable fabric. Light colors. Tuck shirts in.
4. Choose accommodations with screens or air conditioning. Aedes aegypti is a domestic mosquito that breeds in and around homes and hotels. A hotel room with intact screens and AC is meaningfully safer than open-air accommodations near standing water.
5. Drain standing water around your accommodation. Even small water collections (a forgotten water glass, a tray under a potted plant, an uncovered rainwater barrel) can produce Aedes larvae within 8 to 10 days.

Wandr's pre-trip health check generates a personalized prevention plan including these layers, plus optional add-ons like a bed net for any traveler heading to rural Mauritius. The free pre-trip checklist is available at travelwithwandr.com.

Should you still go to Mauritius?

For most US travelers, yes, with the right preparation. The CDC has not advised against non-essential travel. The risk profile, in plain terms:

Lower-risk travelers (recommend going with Ixchiq + prevention):

• Healthy adults 18 to 64
• Travelers staying primarily in resort settings with air-conditioned rooms
• Travelers willing to book Ixchiq at least 28 days before departure

Higher-risk travelers (recommend talking to a clinician before booking):

• Pregnant women, especially in the third trimester or near delivery (chikungunya around delivery carries higher neonatal disease risk)
• Adults 65 and older with comorbidities (Ixchiq adverse-event signals in post-marketing data)
• Immunocompromised travelers (Ixchiq contraindicated; rely on bite prevention only)
• Travelers with chronic joint disease or autoimmune conditions (post-infectious arthritis risk amplifies an existing problem)
• Infants (no chikungunya vaccine for under 18)

If you are in the higher-risk group, we are not telling you not to go. We are telling you to book a pre-trip visit with our clinicians at Wandr before you finalize the trip so we can build a plan that fits your situation.

What to pack for a 2026 Mauritius trip

• Ixchiq vaccination Access is limited in the United States so plan far in advance
• Insect repellent: 20 to 30 percent DEET, 20 percent picaridin, IR3535, or OLE; pack enough for the entire trip
• Permethrin-treated clothing: Long-sleeve shirts, pants, socks; pre-treat or buy pre-treated
• Acetaminophen for fever and joint pain if you do get sick. Avoid aspirin and NSAIDs like ibuprofen until dengue is ruled out, because they can worsen dengue hemorrhagic complications
• Oral rehydration salts (chikungunya causes high fever and dehydration)
• Antihistamine (cetirizine or diphenhydramine) for any allergic reaction to bites
• Travel insurance with medical evacuation, in case you need a transfer to a tertiary hospital (Wellkin or Apollo Bramwell in Mauritius are the main private hospitals, both English-speaking)
• A list of your medications with generic names

What to do if you develop symptoms during or after the trip

Symptoms typically start 3 to 7 days after a mosquito bite. The hallmark is sudden high fever (often above 39 degrees Celsius / 102 degrees Fahrenheit) plus severe joint pain, usually symmetric and most pronounced in the hands, wrists, ankles, and feet. Other symptoms include headache, muscle pain, rash, and fatigue.

If you are in Mauritius:

1. Seek medical care at a private hospital (Wellkin in Moka or Apollo Bramwell in Moka are commonly used by US travelers). Bring your travel insurance card.
2. Confirm the diagnosis. Chikungunya can be confirmed by RT-PCR within the first 7 days of symptoms, or by serology after that.
3. Hydrate aggressively and use acetaminophen for fever and pain. Avoid NSAIDs and aspirin until dengue is ruled out.
4. Rest. Pushing through is the most common reason patients develop the chronic post-chikungunya arthritis.

If you are back in the US and develop symptoms within 12 days of leaving Mauritius:

1. Call our clinicians at Wandr, or your local urgent care or PCP, and tell them you returned from a chikungunya-active country. RT-PCR and serology are widely available in US labs.
2. Avoid NSAIDs and aspirin until dengue is ruled out.
3. Use insect repellent at home for at least 7 days after symptom onset so you do not contribute to local transmission. Aedes albopictus is present in many US states.

How Wandr handles a Mauritius itinerary

The pattern we have built across our travel-vaccine and travel-medication catalog applies cleanly to this outbreak:

1. Free pre-trip health check. A 5-minute questionnaire that captures destination, dates, age, medical history, pregnancy status, allergies, and itinerary specifics. Our clinicians review it and produce a personalized health plan.
2. Ixchiq vaccine appointment booking at a partner Walgreens pharmacy near you. We pick the location and time you choose, the pharmacist administers it on-site.
3. Prescription medications called in to your local pharmacy for pickup before departure. For a Mauritius trip in the current outbreak environment, we commonly route travelers to a prescription anti-nausea medication (ondansetron) and an antibiotic for traveler's diarrhea (azithromycin) in case the trip pivots into a multi-day illness.
4. Travel insurance options with medical evacuation coverage, which is the relevant feature for an Indian Ocean island where complex care may require transfer to Reunion or Johannesburg.

Compared with a traditional travel clinic visit (typical out-of-pocket cost 150 to 250 dollars for the consultation plus 50 to 100 dollars per vaccine administration fee on top of the vaccine cost), Wandr saves most travelers several hundred dollars and a half-day of their time.

FAQ: Mauritius chikungunya for US travelers

How bad is the chikungunya outbreak in Mauritius right now?

Mauritius has reported 2,816 locally acquired confirmed chikungunya cases between January and 11 May 2026, concentrated in the lower and middle Plaines Wilhems district in central Mauritius. The CDC issued a Level 2 Travel Health Notice on 14 May 2026 advising enhanced precautions and the Ixchiq vaccine for eligible US travelers.

Should I cancel my Mauritius trip?

The CDC has not recommended canceling travel. Most healthy adults can safely travel with the Ixchiq vaccine (administered at least 28 days before departure) plus aggressive mosquito-bite prevention. Pregnant women near delivery, adults 65 and older with comorbidities, and immunocompromised travelers should request a Wandr pre-trip clinician review before finalizing the trip.

How do I get the Ixchiq chikungunya vaccine?

Ixchiq is FDA-approved for adults 18 and older. Wandr books your appointment at a partner Walgreens pharmacy near you. Pick a location and time; the pharmacist administers the single-dose vaccine on-site. Onset of protection is about 28 days after vaccination, so book early.

Does the Ixchiq vaccine guarantee I will not get chikungunya?

No vaccine is 100 percent effective. In Phase 3 clinical trials, 98.9 percent of Ixchiq recipients developed a protective antibody response 28 days after a single dose. Mosquito-bite prevention remains an important second layer, especially during the first 28 days after vaccination when protection has not yet developed.

Is chikungunya in Mauritius the same as the outbreak in Reunion or the Seychelles?

The Western Indian Ocean has had sustained chikungunya transmission across multiple islands since 2025, including La Réunion, Mayotte, the Seychelles, Comoros, and now Mauritius. The Mauritius outbreak in 2026 is consistent with regional patterns. If your trip includes more than one Indian Ocean island, treat the entire trip as outbreak-area travel.

Can I travel to Mauritius while pregnant?

Pregnant women, especially those close to delivery, should reconsider non-essential travel to Mauritius right now. Chikungunya infection around the time of delivery carries a higher risk of severe neonatal disease. The Ixchiq vaccine is contraindicated during pregnancy. If you must travel, book a Wandr pre-trip visit so our clinicians can build a maximum-prevention plan.

What is the difference between chikungunya and dengue, and is dengue also a risk in Mauritius?

Both viruses are transmitted by Aedes mosquitoes. Chikungunya causes severe symmetric joint pain that often becomes chronic; dengue causes muscle pain, retro-orbital headache, and rare hemorrhagic complications. Mauritius has historically reported dengue activity as well, so we recommend the same mosquito-bite prevention measures for both.

How long should I avoid NSAIDs if I think I have chikungunya?

Avoid aspirin and NSAIDs (ibuprofen, naproxen) until a clinician has ruled out dengue, because NSAIDs can worsen bleeding complications in dengue hemorrhagic fever. Acetaminophen is safe and effective for fever and joint pain in both viruses.

Where do I find emergency medical care in Mauritius?

Mauritius has two major private hospitals commonly used by international travelers: Wellkin Hospital in Moka and Apollo Bramwell in Moka, both English-speaking and accepting major travel insurance. The emergency number in Mauritius is 999.

How far in advance do I need to plan for a Mauritius trip given this outbreak?

At minimum, schedule the Ixchiq vaccine 28 days before departure for full protection. Six to eight weeks before departure is ideal so we can also handle traveler's diarrhea prescriptions, anti-nausea medication, and travel insurance in the same trip prep window.

Plan your Mauritius trip with Wandr

We built Wandr specifically for outbreak situations like this. The chikungunya vaccine, the bite-prevention plan, the prescription anti-nausea and anti-diarrhea backups, and travel insurance with medical evacuation are all available through a single online visit.

Start your free pre-trip health check. Our clinicians review your itinerary and build a personalized plan in under 24 hours. Start your visit on Wandr.

Book your Ixchiq chikungunya vaccine. Pick a partner pharmacy near you and a time that works; the pharmacist administers the vaccine on-site. Book a vaccine appointment.

Get your prescription medications before you go. Anti-nausea, anti-diarrhea, and acetaminophen-based fever support, called in to your local pharmacy for pickup. Browse travel medications.

Related Wandr coverage

• Chikungunya Vaccine for Travelers: A Complete Guide to Ixchiq
• Dengue Fever in Travelers: A Physician's Complete Guide to Prevention, Symptoms, and Treatment
• Travel Health Guide: Madagascar

Sources

• Centers for Disease Control and Prevention. "Chikungunya in Mauritius, Level 2 Travel Health Notice." CDC Travelers' Health, reviewed 14 May 2026.
• Mauritius Ministry of Health & Wellness. "Chikungunya Situation Updates." Government of Mauritius, May 2026.
• World Health Organization. "Chikungunya Fact Sheet." WHO, 2025 update.
• European Centre for Disease Prevention and Control. "Chikungunya Worldwide Overview." ECDC, May 2026.
• US Food and Drug Administration. "Ixchiq (Chikungunya Vaccine, Live) Prescribing Information." FDA, November 2023.
• Advisory Committee on Immunization Practices. "Use of Chikungunya Vaccine in U.S. Persons Aged ≥18 Years: Recommendations of the ACIP." MMWR, 2024.
• Schwartz O, Albert ML. "Biology and pathogenesis of chikungunya virus." Nature Reviews Microbiology.
• Couderc T, et al. "Maternal-fetal transmission of chikungunya virus." PLOS Medicine.

Medical disclaimer

This article is for informational purposes only and does not constitute medical advice. Wandr Health is a US-licensed telehealth provider; our clinicians can review your specific travel itinerary and medical history before recommending care. For active medical emergencies, call 911 in the US, 999 in Mauritius, or seek the nearest emergency department.